News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,747 Results
Type
Article (68405)
Company Profile (450)
Press Release (676892)
Section
Business (200966)
Career Advice (3528)
Deals (36640)
Drug Delivery (123)
Drug Development (85811)
Employer Resources (194)
FDA (16790)
Job Trends (15730)
News (350056)
Policy (34297)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (10)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (16)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (8)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (11)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (7)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2948)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (88)
Alliances (50684)
ALS (92)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (134)
Approvals (16760)
Artificial intelligence (272)
Autoimmune disease (22)
Automation (14)
Bankruptcy (350)
Best Places to Work (12224)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (332)
Bladder cancer (65)
Brain cancer (28)
Breast cancer (269)
Cancer (2139)
Cardiovascular disease (185)
Career advice (2990)
Career pathing (33)
CAR-T (160)
Cell therapy (451)
Cervical cancer (21)
Clinical research (69070)
Collaboration (833)
Compensation (463)
Complete response letters (29)
COVID-19 (2804)
CRISPR (43)
C-suite (232)
Cystic fibrosis (105)
Data (2015)
Decentralized trials (2)
Denatured (37)
Depression (50)
Diabetes (270)
Diagnostics (6696)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (124)
Drug pricing (117)
Drug shortages (33)
Duchenne muscular dystrophy (92)
Earnings (75471)
Editorial (39)
Employer branding (25)
Employer resources (166)
Events (119952)
Executive appointments (685)
FDA (17951)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (742)
Gene editing (110)
Generative AI (27)
Gene therapy (323)
GLP-1 (802)
Government (4941)
Grass and pollen (5)
Guidances (47)
Healthcare (20253)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (126)
Indications (27)
Infectious disease (2946)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (50)
Intellectual property (90)
Interviews (683)
IPO (17061)
IRA (47)
Job creations (3982)
Job search strategy (2458)
Kidney cancer (9)
Labor market (35)
Layoffs (530)
Leadership (20)
Legal (7962)
Liver cancer (73)
Lung cancer (314)
Lymphoma (137)
Machine learning (4)
Management (65)
Manufacturing (298)
MASH (66)
Medical device (13871)
Medtech (13876)
Mergers & acquisitions (20095)
Metabolic disorders (715)
Multiple sclerosis (74)
NASH (23)
Neurodegenerative disease (101)
Neuropsychiatric disorders (30)
Neuroscience (1995)
NextGen: Class of 2025 (7275)
Non-profit (4875)
Northern California (2466)
Now hiring (38)
Obesity (390)
Opinion (268)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (78)
Parkinson's disease (142)
Partnered (20)
Patents (216)
Patient recruitment (96)
Peanut (51)
People (61821)
Pharmaceutical (88)
Pharmacy benefit managers (20)
Phase I (21551)
Phase II (30280)
Phase III (22629)
Pipeline (1084)
Podcasts (104)
Policy (135)
Postmarket research (2865)
Preclinical (9429)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (401)
Real estate (6502)
Recruiting (75)
Regulatory (23517)
Reports (53)
Research institute (2598)
Resumes & cover letters (556)
Rett syndrome (3)
RNA editing (4)
RSV (46)
Schizophrenia (74)
Series A (132)
Series B (84)
Service/supplier (15)
Sickle cell disease (57)
Southern California (2146)
Special edition (18)
Spinal muscular atrophy (160)
Sponsored (33)
Startups (3817)
State (2)
Stomach cancer (16)
Supply chain (63)
The Weekly (65)
United States (22158)
Vaccines (737)
Venture capitalists (39)
Webinars (13)
Weight loss (282)
Women's health (37)
Worklife (18)
Date
Today (160)
Last 7 days (782)
Last 30 days (2962)
Last 365 days (35450)
2025 (8647)
2024 (37040)
2023 (41691)
2022 (52799)
2021 (57741)
2020 (56396)
2019 (49878)
2018 (37838)
2017 (34983)
2016 (35060)
2015 (40758)
2014 (33914)
2013 (29654)
2012 (31323)
2011 (31596)
2010 (30322)
Location
Africa (1052)
Alabama (56)
Alaska (7)
Arizona (212)
Arkansas (14)
Asia (44081)
Australia (7721)
California (5696)
Canada (1888)
China (505)
Colorado (254)
Connecticut (275)
Delaware (130)
Europe (100712)
Florida (837)
Georgia (200)
Hawaii (1)
Idaho (61)
Illinois (565)
India (26)
Indiana (307)
Iowa (10)
Japan (144)
Kansas (102)
Kentucky (25)
Louisiana (9)
Maine (68)
Maryland (873)
Massachusetts (4423)
Michigan (233)
Minnesota (388)
Mississippi (2)
Missouri (85)
Montana (30)
Nebraska (25)
Nevada (56)
New Hampshire (64)
New Jersey (1638)
New Mexico (31)
New York (1652)
North Carolina (1027)
North Dakota (8)
Northern California (2466)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1275)
Puerto Rico (10)
Rhode Island (26)
South America (1404)
South Carolina (19)
South Dakota (1)
Southern California (2146)
Tennessee (92)
Texas (849)
Utah (174)
Virginia (137)
Washington D.C. (63)
Washington State (544)
West Virginia (3)
Wisconsin (58)
745,747 Results for "the chinese academy of sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVersys Announces Important BV100 Patent Granted by Chinese Patent Office
March 31, 2025
·
5 min read
ADCs
ArriVent Joins Chinese Licensing Trend With Potential $1.2B+ ADC Deal with Lepu
With an eye toward advancing a novel antibody-drug conjugate for gastrointestinal cancers, ArriVent is the latest biopharma player to ink a deal with a Chinese biotech.
January 22, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting
March 21, 2025
·
6 min read
Press Releases
CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia and Other Related Disorders at the American Academy of Neurology 2025 Annual Meeting
March 28, 2025
·
5 min read
Press Releases
Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting
March 7, 2025
·
5 min read
Press Releases
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
March 3, 2025
·
5 min read
BioForest
Indapta Therapeutics to Highlight its g-NK Cell Platform for the Treatment of Cancer and Autoimmune Disease in a Plenary Session at New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference
Indapta Therapeutics, Inc. announced that CEO Mark Frohlich, MD, will be giving a plenary talk today titled, “g-NK cells for the treatment of cancer and autoimmune disease” at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference.
May 23, 2024
·
3 min read
China
Bayer Jumps on Chinese Partnership Train with Oncology Deal
The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed.
March 26, 2025
·
1 min read
·
Dan Samorodnitsky
Biotech Bay
First-in-Disease Use of Kyverna Therapeutics’ KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS)
Kyverna Therapeutics, Inc. (Kyverna) announced today the publication in Proceedings of the National Academy of Sciences (PNAS)1 of a report describing the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in a 69-year-old patient suffering from treatment-refractory stiff-person syndrome (SPS) as part of a named-patient use in Germany for critically ill individuals who fail conventional therapies.
June 17, 2024
·
6 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
March 10, 2025
·
15 min read
1 of 74,575
Next
